Search Results for ""
- Online Learning Center (468)
- Policy Library (2791)
- Performance Measures (279)
- Annals of Internal Medicine (6848)
- Annals of Internal Medicine: Clinical Cases (500)
- IM Matters (3144)
- ACP Hospitalist (2393)
- ACP Diabetes Monthly (990)
- ACP Gastroenterology Monthly (933)
Displaying 1 - 10 of 468 in Online Learning Center
Women's Health
A collection of educational materials in the Online Learning Center.
Viral Infections
A collection of activities in the Online Learning Center.
Venous Thromboembolism
A collection of venous thromboembolism activities in the Online Learning Center.
Vector-borne Diseases
A collection of activities in the Online Learning Center.
Vasculitis
A collection of educational materials in the Online Learning Center.
Valvular Heart Disease
A collection of educational materials in the Online Learning Center.
Vaccination/Immunization
A collection of immunization and vaccination activities in the Online Learning Center.
Urologic Cancer
A collection of educational materials in the Online Learning Center.
Travel Medicine
A collection of activities in the Online Learning Center.
Thrombotic Disorders
A collection of educational materials in the Online Learning Center.
Displaying 1 - 10 of 2791 in Policy Library
Displaying 1 - 10 of 279 in Performance Measures
Performance Measures
Performance measurement allows us to assess healthcare against evidence-based clinical guidelines and nationally recognized standards of care.
Zoster (Shingles) Vaccination
The percentage of patients 50 years of age and older who have a Varicella Zoster (shingles) vaccination.
Vitamin D Level - Effective Control of Low Bone Mass/Osteopenia and Osteoporosis: Therapeutic Level Of 25 OH Vitamin D Level Achieved
Percentage of patients aged 65 years and older diagnosed with osteopenia or osteoporosis whose most recent serum 25 Hydroxy-Vitamin D results is greater than or equal to 30.0 ng/dL
Venous Thromboembolism Prophylaxis
This measure assesses the number of patients who received venous thromboembolism (VTE) prophylaxis or have documentation why no VTE prophylaxis was given the day of or the day after hospital admission or surgery end date for surgeries that start the day of or the day after hospital admission. This measure is part of a set of six nationally implemented prevention and treatment measures that address VTE (VTE-2: ICU VTE Prophylaxis, VTE-3: VTE Patients with Anticoagulation Overlap Therapy, VTE-4: VTE Patients Receiving UFH with Dosages/Platelet Count Monitoring, VTE-5: VTE Warfarin Therapy Discharge Instructions and VTE-6: Hospital Acquired Potentially-Preventable VTE) that are used in The Joint Commission’s accreditation process.
Use of Opioids from Multiple Providers in Persons without Cancer
The proportion (XX out of 1,000) of individuals without cancer receiving prescriptions for opioids from four (4) or more prescribers AND four (4) or more pharmacies.
Use of Opioids from Multiple Providers and at High Dosage in Persons without Cancer
The proportion (XX out of 1,000) of individuals without cancer receiving prescriptions for opioids with a daily dosage greater than 120mg morphine equivalent dose (MED) for 90 consecutive days or longer, AND who received opioid prescriptions from four (4) or more prescribers AND four (4) or more pharmacies.
Use of Opioids at High Dosage in Persons Without Cancer
The proportion (XX out of 1,000) of individuals without cancer receiving prescriptions for opioids with a daily dosage greater than 120mg morphine equivalent dose (MED) for 90 consecutive days or longer
Use of Imaging Studies for Low Back Pain
The percentage of patients with a primary diagnosis of low back pain who did not have an imaging study (plain X-ray, MRI, CT scan) within 28 days of diagnosis
Use of High-Risk Medications in the Elderly
Percentage of patients 66 years of age and older who were ordered high-risk medications. Two rates are reported: a. Percentage of patients who were ordered at least one high-risk medication b. Percentage of patients who were ordered at least two different high-risk medications.
Use of Appropriate Medications for People with Asthma
INACTIVE REVIEW: This measure review is older than five years. The percentage of patients 5-64 years of age during the measurement year who were identified as having persistent asthma and who were appropriately prescribed medication during the measurement year
Displaying 1 - 10 of 6848 in Annals of Internal Medicine
These Annals of Internal Medicine results only contain recent articles.
- Visit annals.org to search all content back to 1927.
- View Annals of Internal Medicine CME by topic here.
Displaying 1 - 10 of 500 in Annals of Internal Medicine: Clinical Cases
Sequential Drug-Induced DRESS Syndrome With Severe Rhabdomyolysis and Probable Myocarditis: A Case Report | Annals of Internal Medicine: Clinical Cases
DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) is a severe hypersensitivity syndrome with multiorgan involvement. An 81-year-old man with cardiomyopathy and stage IV chronic kidney disease developed DRESS syndrome after sequential exposure to allopurinol and vancomycin. He presented with diffuse rash, eosinophilia, transaminitis, severe rhabdomyolysis (CK 19,228 U/L), and probable myocarditis (troponin 9,712 ng/L). Corticosteroids started late, and a repeat vancomycin dose was temporally associated with rapid multiorgan deterioration and death. This case illustrates a rare presentation of DRESS syndrome with concurrent rhabdomyolysis and myocarditis, emphasizing the lethality of delayed diagnosis and sequential exposure to high-risk agents.
Chronic Pulmonary Aspergillosis: Bronchoscopic Visualization of a Cavitary Aspergilloma | Annals of Internal Medicine: Clinical Cases
Chronic pulmonary aspergillosis is a common condition seen in immunocompetent patients with lung structural damage. Sometimes, a fungal ball-like mass forms inside a lesion, leading to recurrent hemoptysis. Direct visualization of the aspergilloma inside the cavity is rarely possible; however, this case highlights this unusual presentation.
A Case of Crystal-Proven Calcium Pyrophosphate Deposition Disease in the Sternoclavicular Joint | Annals of Internal Medicine: Clinical Cases
Calcium pyrophosphate deposition disease (CPPD) is an important cause of crystalline arthritis commonly involving the knees and wrists, although many joints can be affected. Calcium pyrophosphate deposition disease of the sternoclavicular (SC) joints has been described rarely and historically has either been unconfirmed or reliant on surgical pathology for diagnosis. We describe a patient with episodic pain and swelling of the SC joint with corresponding chondrocalcinosis on computed tomography imaging and subsequent image-guided aspiration that confirmed presence of CPPD crystals. To our knowledge, this is the first reported case of crystal-proven CPPD by arthrocentesis of the SC joint.
An Unrecognized Case of Glanzmann Thrombasthenia Associated With Gastrointestinal Bleeding | Annals of Internal Medicine: Clinical Cases
Glanzmann thrombasthenia (GT) is a rare autosomal-recessive platelet disorder caused by deficiency or dysfunction of glycoprotein IIb/IIIa, resulting in defective aggregation and mucocutaneous bleeding. We report a 22-year-old Egyptian man presenting with gastrointestinal bleeding, severe anemia, and lifelong unexplained bleeding. Endoscopy revealed edematous gastropathy with postbiopsy bleeding exacerbation. Common coagulopathies were excluded and platelet aggregation tests showed absent responses to adenosine diphosphate, collagen, and arachidonic acid, confirming GT by flow cytometry. He was successfully treated with recombinant activated factor VII and tranexamic acid. This case underscores the importance of considering GT in patients with unexplained mucocutaneous bleeding and normal coagulation.
Cardiac Tamponade Due to Entamoeba histolytica in a Patient in a Nonendemic Region | Annals of Internal Medicine: Clinical Cases
Entamoeba histolytica infection is classically associated with intestinal disease and liver abscesses in endemic regions. Pericardial involvement with cardiac tamponade is an exceptionally rare, life-threatening complication. We present a case of a 58-year-old man in the United States with no recent travel who developed pericardial tamponade due to diaphragmatic communication with an E histolytica liver abscess. His case underscores the need to consider parasitic infections in the differential diagnosis of purulent pericardial effusions, even in nonendemic areas, and demonstrates how serologic testing and multidisciplinary collaboration were critical for diagnosis and management of this unexpected condition.
Retatrutide-Induced Intractable Diarrhea | Annals of Internal Medicine: Clinical Cases
Gastrointestinal symptoms accompanying the use of glucagon-like peptide-1 (GLP-1) receptor agonists and glucose-dependent insulinotropic polypeptide receptor-GLP-1 receptor co-agonists have been extensively catalogued. This case report contains a dramatic presentation of unintended consequences from the use of a novel triple-hormone receptor agonist and points toward the need for increased regulatory measures regarding the marketing of these treatments.